Cover Image

Editorial: Can dietary gluten restriction improve hepatic steatosis?

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hariklia Kranidioti, Melanie Deutsch
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Viral hepatitis elimination: Still a big challenge: Care is not only for C
by: Nikolaos Papadopoulos, et al.
Published: (2024)

Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study
by: Angelo Armandi, et al.
Published: (2024)

Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?
by: Fahim Ebrahimi, et al.
Published: (2024)

Editorial: Solving the acute kidney injury puzzle in alcohol‐associated hepatitis—Challenges and insights
by: Vishnu Girish, et al.
Published: (2024)

Editorial: Stopping NUCs—When to Restart NUCs for the Best Outcome?
by: Melanie Urbanek‐Quaing, et al.
Published: (2024)

Editorial: Can We Prevent Inflammatory Bowel Disease?
by: Agnes Hiu Yan Ho, et al.
Published: (2025)

Editorial: Can we predict or not predict response to hypnotherapy? That is the question
by: Jenny Lövdahl, et al.
Published: (2024)

Editorial: How does the risk of hepatocellular carcinoma change over time in patients with a hepatitis C cure? Authors' reply
by: Philip Vutien, et al.
Published: (2024)

Letter: Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in chronic hepatitis B virus infection
by: Jianrong Li, et al.
Published: (2024)

Editorial: Hepatitis C virus eradication improves skeletal muscle mass
by: Catherine Jia Lin Tian, et al.
Published: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
by: Peter R. Gibson, et al.
Published: (2024)

Editorial: Can We Prevent Inflammatory Bowel Disease? Authors' Reply
by: Fai Fai Ho, et al.
Published: (2025)

Letter: Effect of dietary additives on intestinal barrier and acute stress in healthy adults
by: Liqi Li
Published: (2024)

Editorial: Can we predict or not predict response to hypnotherapy? That is the question. Authors' reply
by: Dipesh H. Vasant, et al.
Published: (2024)

Editorial: Hepatitis C virus eradication improves skeletal muscle mass—Authors' reply
by: Marta Paula Pereira Coelho, et al.
Published: (2024)

Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection
by: Na‐Ling Kang, et al.
Published: (2024)

Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet?
by: Joyce Wing Yan Mak
Published: (2025)

Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
by: Iris Barth, et al.
Published: (2024)

Editorial: MetALD and Risk of Gastrointestinal Cancer—What Can We Learn From Japan?
by: Hannes Hagström, et al.
Published: (2025)

Letter: Association between chronic kidney disease, hepatitis B and antiviral treatments
by: Chen‐Pi Li, et al.
Published: (2024)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B
by: Jian Wang, et al.
Published: (2024)

Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet? Author's Reply
by: Aurelien Amiot, et al.
Published: (2025)

Low socioeconomic status exacerbates unmet health‐related needs in patients with autoimmune hepatitis
by: Carolyn Singleton, et al.
Published: (2024)

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors
by: Matthew J. Townsend, et al.
Published: (2024)

Development of hepatic fibrosis in common variable immunodeficiency‐related porto‐sinusoidal vascular disorder
by: Julian Hercun, et al.
Published: (2024)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B—Author's reply
by: Hyeyeon Hong, et al.
Published: (2024)

Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective‐prospective study
by: Elena Vargas‐Accarino, et al.
Published: (2024)

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease
by: Nabil Noureddin, et al.
Published: (2024)

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
by: Jian Wang, et al.
Published: (2024)

Editorial: M et ALD and Risk of Gastrointestinal Cancer—What Can We Learn From Japan? Authors' Reply
by: Nobuharu Tamaki, et al.
Published: (2025)

Outcomes of patients with alcohol‐associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium
by: Ann T. Ma, et al.
Published: (2024)

The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
by: Fangyuan Jiang, et al.
Published: (2024)

Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply
by: Yu‐Sheng Lin, et al.
Published: (2026)

Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality
by: Lukas Hartl, et al.
Published: (2024)

Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis B
by: Jing Li, et al.
Published: (2024)

Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
by: Jung Eun Park, et al.
Published: (2024)

CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance
by: Hye Won Lee, et al.
Published: (2024)

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
by: Lisa Sandmann, et al.
Published: (2024)

Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis B ‐ authors' reply
by: WenXian OuYang, et al.
Published: (2024)

Editorial: PSC as an Independent Risk Factor for CRC Without IBD : Can Observed Epidemiological Trends Help Uncover Biological Mechanisms and Guide Surveillance Strategies?
by: Natassia Tan, et al.
Published: (2025)